Normal function of HERG K+ channels expressed in HEK293 cells requires basal protein kinase B activity

FEBS Lett. 2003 Jan 16;534(1-3):125-32. doi: 10.1016/s0014-5793(02)03804-8.

Abstract

The potential role of protein kinase B (PKB), a serine/threonine protein kinase, in regulating HERG (human ether-a-go-go related gene) K(+) channel function was investigated. Wortmannin (a phosphoinositide 3-kinase (PI3K) inhibitor) caused approximately 30% reduction of HERG current (I(HERG)) stably expressed in HEK293 cells. Transient transfection with the constitutively active PI3K in HERG-expressing HEK293 cells slightly increased ( approximately 7%) I(HERG) while a dominant negative PI3K significantly reduced I(HERG) ( approximately 25%) relative to results in vehicle-transfected cells. I(HERG) was approximately 35% greater in cells transfected with the constitutively activated PKB (caPKB), whereas it was approximately 47% smaller in cells transfected with dominant negative PKB (dnPKB). Basal activation of PKB was detected by immunocytochemistry. PKB activity was significantly enhanced in caPKB-transfected cells and nearly abolished in dnPKB-transfected cells. We conclude that normal HERG function in HEK293 cells requires basal activity of PKB. Our data represent the first evidence that PKB phosphorylation regulates K(+) channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology
  • CD8 Antigens / metabolism
  • Cation Transport Proteins*
  • Cell Line
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • DNA-Binding Proteins*
  • ERG1 Potassium Channel
  • Enzyme Inhibitors / pharmacology
  • Ether-A-Go-Go Potassium Channels
  • Genes, Dominant
  • Humans
  • Immunohistochemistry / methods
  • Isoquinolines / pharmacology
  • Patch-Clamp Techniques
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Potassium Channels / metabolism*
  • Potassium Channels, Voltage-Gated*
  • Protein Serine-Threonine Kinases*
  • Proto-Oncogene Proteins / drug effects
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-akt
  • Sulfonamides*
  • Trans-Activators*
  • Transcriptional Regulator ERG
  • Transfection
  • Wortmannin

Substances

  • Androstadienes
  • CD8 Antigens
  • Cation Transport Proteins
  • DNA-Binding Proteins
  • ERG protein, human
  • ERG1 Potassium Channel
  • Enzyme Inhibitors
  • Ether-A-Go-Go Potassium Channels
  • Isoquinolines
  • KCNH2 protein, human
  • KCNH6 protein, human
  • Phosphoinositide-3 Kinase Inhibitors
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Proto-Oncogene Proteins
  • Sulfonamides
  • Trans-Activators
  • Transcriptional Regulator ERG
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • Wortmannin